Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qiaowei Fan & Bingrong Liu. (2017) Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis. OncoTargets and Therapy 10, pages 3591-3606.
Read now
Read now
Tao Chen, Peng Yang, Hui Wang & Zhen-Yu He. (2017) Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells. OncoTargets and Therapy 10, pages 483-491.
Read now
Read now
Pooneh Mokarram, Mohammed Albokashy, Maryam Zarghooni, Mohammad Amin Moosavi, Zahra Sepehri, Qi Min Chen, Andrzej Hudecki, Aliyeh Sargazi, Javad Alizadeh, Adel Rezaei Moghadam, Mohammad Hashemi, Hesam Movassagh, Thomas Klonisch, Ali Akbar Owji, Marek J. Łos & Saeid Ghavami. (2017) New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. Autophagy 13:5, pages 781-819.
Read now
Read now
Benjamin Chastek, Mahesh Kulakodlu, Satish Valluri & Brian Seal. (2013) Impact of Metastatic Colorectal Cancer Stage and Number of Treatment Courses on Patient Health Care Costs and Utilization. Postgraduate Medicine 125:2, pages 73-82.
Read now
Read now
Articles from other publishers (92)
Cornelia Amalinei, Diana-Lavinia Pricope & Adriana Grigoras¸. 2024. Cancer Stem Cells and Signaling Pathways. Cancer Stem Cells and Signaling Pathways
185
205
.
Mahdi Bahrami Parsa, Farzaneh Tafvizi, Vahid Chaleshi & Mostafa Ebadi. (2023) Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer Activities. Heliyon 9:10, pages e20657.
Crossref
Crossref
Po-Li Wei, Chien-Yu Huang, Tung-Cheng Chang, Jang-Chun Lin, Cheng-Chin Lee, G. M. Shazzad Hossain Prince, Precious Takondwa Makondi, Angelina Wong-Ying Chui & Yu-Jia Chang. (2023) PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway. International Journal of Molecular Sciences 24:12, pages 10008.
Crossref
Crossref
Melody D. Fulton & Wided Najahi-Missaoui. (2023) Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. International Journal of Molecular Sciences 24:7, pages 6615.
Crossref
Crossref
Sadra Samavarchi Tehrani, Fataneh Esmaeili, Moein Shirzad, Golnaz Goodarzi, Tooba Yousefi, Mahmood Maniati, Mortaza Taheri‐Anganeh & Amir Anushiravani. (2023) The critical role of circular RNAs in drug resistance in gastrointestinal cancers. Medical Oncology 40:4.
Crossref
Crossref
Samar Al Bitar, Marwan El-Sabban, Samer Doughan & Wassim Abou-Kheir. (2023) Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond. World Journal of Gastroenterology 29:9, pages 1395-1426.
Crossref
Crossref
Guang-Yue Li, Shu-Jing Zhang, Dong Xue, Yue-Qi Feng, Yan Li, Xun Huang, Qiang Cui, Bo Wang, Jun Feng, Tao Bao, Pei-Jun Liu, Shao-Ying Lu & Ji-Chang Wang. (2023) Overcoming chemoresistance in non-angiogenic colorectal cancer by metformin via inhibiting endothelial apoptosis and vascular immaturity. Journal of Pharmaceutical Analysis 13:3, pages 262-275.
Crossref
Crossref
Julika Schlosser & Heiko Ihmels. (2023) Ligands for Abasic Site-containing DNA and their Use as Fluorescent
Probes. Current Organic Synthesis 20:1, pages 96-113.
Crossref
Crossref
Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang, Weiwei Cui, Yunling Xiao, Lanlan Liu, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen, Jie Chai & Jing Hao. (2023) Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription. Molecular Cancer Research 21:2, pages 115-126.
Crossref
Crossref
Halilibrahim Ciftci, Belgin Sever, Nusret Kaya, Nilüfer Bayrak, Mahmut Yıldız, Hatice Yıldırım, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita & Amaç Fatih TuYuN. (2022) Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects. Molecules 28:1, pages 77.
Crossref
Crossref
Yonghui Wang, Xiaodong Ma, Wenhui Zhou, Chang Liu & Hongbo Zhang. (2022) Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer. Smart Medicine 1:1.
Crossref
Crossref
Jingbo Yang, Chengyan He & Ning Liu. (2022) Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU. Frontiers in Medicine 9.
Crossref
Crossref
Cheng-Zhi Huang, Yue Zhou, Qi-Song Tong, Qi-Jia Duan, Qing Zhang, Jin-Zhi Du & Xue-Qing Yao. (2022) Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials 290, pages 121827.
Crossref
Crossref
Guanglong Chen, Ting Gong, Zhe Wang, Zeyu Wang, Xiaolin Lin, Sunrui Chen, Chu Sun, Weijie Zhao, Ye Kong, Huihan Ai, Hang Yang, Yusheng Liu, Fangyan Wu, Jiawei Kang, Shasha Zhao, Xiuying Xiao, Jing Sun, Aina He & Zhi Li. (2022) Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Cellular Oncology.
Crossref
Crossref
Cong Liu, Dingwei Liu, Fangfei Wang, Jun Xie, Yang Liu, Huan Wang, Jianfang Rong, Jinliang Xie, Jinyun Wang, Rong Zeng, Feng Zhou & Yong Xie. (2022) An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Frontiers in Medicine 9.
Crossref
Crossref
Navami Koyande, Madhusree Gangopadhyay, Shashidhar Thatikonda & Aravind Kumar Rengan. (2022) The role of gut microbiota in the development of colorectal cancer: a review. International Journal of Colorectal Disease 37:7, pages 1509-1523.
Crossref
Crossref
Upasana RayChristopher L. PathoulasPrabhu ThirusanguJames W. PurcellNagarajan Kannan & Viji Shridhar. (2022) Exploiting LRRC15 as a Novel Therapeutic Target in Cancer. Cancer Research 82:9, pages 1675-1681.
Crossref
Crossref
Cyrollah Disoma, Yuzheng Zhou, Shanni Li, Jian Peng & Zanxian Xia. (2022) Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?. Biochimie 195, pages 39-53.
Crossref
Crossref
Upasana Ray, Deok-Beom Jung, Ling Jin, Yinan Xiao, Subramanyam Dasari, Sayantani Sarkar Bhattacharya, Prabhu Thirusangu, Julie K. Staub, Debarshi Roy, Bhaskar Roy, S. John Weroha, Xiaonan Hou, James W. Purcell, Jamie N. Bakkum-Gamez, Scott H. Kaufmann, Nagarajan Kannan, Anirban K. Mitra & Viji Shridhar. (2022) Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer. Cancer Research 82:6, pages 1038-1054.
Crossref
Crossref
Marie Malier, Khaldoun Gharzeddine, Marie-Hélène Laverriere, Thomas Decaens, Gael Roth & Arnaud Millet. (2022) Les macrophages associés à la tumeur. médecine/sciences 38:3, pages 243-245.
Crossref
Crossref
Yan Dang, Shutian Zhang, Yongjun Wang, Guiping Zhao, Chuyan Chen & Wei Jiang. (2022) State-of-the-Art: Exosomes in Colorectal Cancer. Current Cancer Drug Targets 22:1, pages 2-17.
Crossref
Crossref
Zhao-liang Yu, Yu-feng Chen, Bin Zheng, Ze-rong Cai, Yi-feng Zou, Jia Ke, Ping Lan, Feng Gao & Xiao-jian Wu. (2021) Protein–protein interaction analysis reveals a novel cancer stem cell related target TMEM17 in colorectal cancer. Cancer Cell International 21:1.
Crossref
Crossref
Marie Malier, Khaldoun Gharzeddine, Marie-Hélène Laverriere, Sabrina Marsili, Fabienne Thomas, Magali Court, Thomas Decaens, Gael Roth & Arnaud Millet. (2021) Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer. Cancer Research 81:23, pages 5963-5976.
Crossref
Crossref
Yeting Hu, Yucheng Qian, Jingsun Wei, Tian Jin, Xiangxing Kong, Hongfeng Cao & Kefeng Ding. (2021) The Disulfiram/Copper Complex Induces Autophagic Cell Death in Colorectal Cancer by Targeting ULK1. Frontiers in Pharmacology 12.
Crossref
Crossref
Siao-Syun Guan, Cheng-Tien Wu, Tse-Zung Liao, Kun-Liang Lin, Cheng-Liang Peng, Ying-Hsia Shih, Mao-Feng Weng, Chun-Tang Chen, Chung-Hsin Yeh, Ying-Chieh Wang & Shing‑Hwa Liu. (2021) A novel 111indium-labeled dual carbonic anhydrase 9-targeted probe as a potential SPECT imaging radiotracer for detection of hypoxic colorectal cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 38-52.
Crossref
Crossref
Zhi-hai Zheng, He-yi You, Yu-jie Feng & Zhong-tao Zhang. (2020) LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells. Molecular and Cellular Biochemistry 476:7, pages 2575-2585.
Crossref
Crossref
Wei Sun, Yang Ge, Junpeng Cui, Yifan Yu & Baolin Liu. (2021) Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2. Molecular Therapy - Oncolytics 21, pages 87-97.
Crossref
Crossref
Yunpeng Lei, Lirui He, Chang Yan, Yuchen Wang & Guoqing Lv. (2021) PERK activation by CCT020312 chemosensitizes colorectal cancer through inducing apoptosis regulated by ER stress. Biochemical and Biophysical Research Communications 557, pages 316-322.
Crossref
Crossref
Yuru Shang, Xianbin Zhang, Lili Lu, Ke Jiang, Mathias Krohn, Stephanie Matschos, Christina Susanne Mullins, Brigitte Vollmar, Dietmar Zechner, Peng Gong & Michael Linnebacher. (2021) Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells. British Journal of Cancer 124:8, pages 1411-1420.
Crossref
Crossref
Min-Kyoung Shin, Yong-Deok Jeon, Seung-Heon Hong, Sa-Haeng Kang, Ji-Ye Kee & Jong-Sik Jin. (2021) In Vivo and In Vitro Effects of Tracheloside on Colorectal Cancer Cell Proliferation and Metastasis. Antioxidants 10:4, pages 513.
Crossref
Crossref
Céline Hervieu, Niki Christou, Serge Battu & Muriel Mathonnet. (2021) The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials. Cancers 13:5, pages 1092.
Crossref
Crossref
Xiaoling Fu, Yanbo Zhang, Lisheng Chang, Dengcheng Hui, Ru Jia, Ningning Liu, Huayue Zhang, Gang Han, Zhifen Han, Yuan Li, Hui Liu, Huirong Zhu & Qi Li. (2020) The JPJDF has Synergistic Effect with Fluoropyrimidine in the Maintenance Therapy for Metastatic Colorectal Cancer. Recent Patents on Anti-Cancer Drug Discovery 15:3, pages 257-269.
Crossref
Crossref
Ashish Tyagi, Balaji Chandrasekaran, Venkatesh Kolluru, Becca V. Baby, Cibi A. Sripathi, Murali K. Ankem, Srinivasa R. Ramisetti, Venkat R. Chirasani, Nikolay V. Dokholyan, Arun K. Sharma & Chendil Damodaran. (2020)
ASR490, a Small Molecule, Overrides Aberrant Expression of
Notch1
in Colorectal Cancer
. Molecular Cancer Therapeutics 19:12, pages 2422-2431.
Crossref
Crossref
Tianqi Dong, Yuncang Yuan, Xudong Xiang, Shuping Sang, Hao Shen, Lei Wang, Chunyan Yang, Fangfang Li, Hongliang Li & Shangyong Zheng. (2020) High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer. PeerJ 8, pages e10397.
Crossref
Crossref
Jose J.G. Marin, Rocio I.R. Macias, Maria J. Monte, Elisa Herraez, Ana Peleteiro-Vigil, Beatriz Sanchez de Blas, Paula Sanchon-Sanchez, Alvaro G. Temprano, Ricardo A. Espinosa-Escudero, Elisa Lozano, Oscar Briz & Marta R. Romero. (2020) Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. Cancers 12:9, pages 2605.
Crossref
Crossref
Helon Guimarães Cordeiro, Alessandra Valéria de Sousa Faria & Carmen Veríssima Ferreira-Halder. (2020) Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ). Biological Chemistry 401:9, pages 1063-1069.
Crossref
Crossref
Chiyo Nakashima-Nakasuga, Shoichi Hazama, Nobuaki Suzuki, Yuki Nakagami, Ming Xu, Shin Yoshida, Shinobu Tomochika, Nobuyuki Fujiwara, Satoshi Matsukuma, Hiroto Matsui, Yukio Tokumitsu, Shinsuke Kanekiyo, Yoshitaro Shindo, Noriko Maeda, Ryouichi Tsunedomi, Michihisa Iida, Shigeru Takeda, Shigefumi Yoshino, Tomio Ueno, Yoshihiko Hamamoto, Hiroyuki Ogihara, Yoshinobu Hoshii & Hiroaki Nagano. (2020) Serum LOX-1 is a novel prognostic biomarker of colorectal cancer. International Journal of Clinical Oncology 25:7, pages 1308-1317.
Crossref
Crossref
Neslisah Barlak, Fatma Sanli, Ozel Capik, Elanur Tuysuz, Elanur Aydın Karatas, Hasan Turkez & Omer Faruk Karatas. (2020) Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep- 2 to 5-Fluorouracil. Clinical Cancer Drugs 7:1, pages 16-24.
Crossref
Crossref
Giovannina Barisciano, Tommaso Colangelo, Valeria Rosato, Livio Muccillo, Maria Letizia Taddei, Luigi Ippolito, Paola Chiarugi, Mario Galgani, Sara Bruzzaniti, Giuseppe Matarese, Matteo Fassan, Marco Agostini, Francesca Bergamo, Salvatore Pucciarelli, Annalucia Carbone, Gianluigi Mazzoccoli, Vittorio Colantuoni, Fabrizio Bianchi & Lina Sabatino. (2020) miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. British Journal of Cancer 122:9, pages 1354-1366.
Crossref
Crossref
Xiuyun Sun & Yu Rao. (2019) PROTACs as Potential Therapeutic Agents for Cancer Drug Resistance. Biochemistry 59:3, pages 240-249.
Crossref
Crossref
Xiuyun Sun, Hongying Gao, Yiqing Yang, Ming He, Yue Wu, Yugang Song, Yan Tong & Yu Rao. (2019) PROTACs: great opportunities for academia and industry. Signal Transduction and Targeted Therapy 4:1.
Crossref
Crossref
Loka Reddy Velatooru, Sridhar Vakamullu, Vasudevarao Penugurti & Purushotham Reddy S.. (2019) Alpinoid c analog inhibits angiogenesis and induces apoptosis in COLO205 cell line. Chemico-Biological Interactions 308, pages 1-10.
Crossref
Crossref
Xue-Cen Wang, Xin Yue, Rong-Xin Zhang, Ting-Yu Liu, Zhi-Zhong Pan, Meng-Jie Yang, Zhen-Hai Lu, Zi-Yang Wang, Jian-Hong Peng, Li-Yuan Le, Gao-Yuan Wang, Qi-Hua Peng, Yuan Meng, Wenlin Huang & Ran-Yi Liu. (2019) Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair. Clinical Cancer Research 25:14, pages 4567-4579.
Crossref
Crossref
Jian Cai, Huaiming Wang, Xiaodong Jiao, Rongkang Huang, Qiyuan Qin, Jianwei Zhang, Honglei Chen, Dan Feng, Xin Tian & Hui Wang. (2019) The RNA-Binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer By Upregulating CDC6. Molecular Cancer Therapeutics 18:7, pages 1243-1254.
Crossref
Crossref
Jun Li, Xiang Ni, Jingtian Zhang, Yong Liang, Zhiyuan Gao, Xiaoyan Zhang, Donghui Zheng & Dan Ding. (2019) A fluorescence and photoactivity dual-activatable prodrug with self-synergistic magnification of the anticancer effect. Materials Chemistry Frontiers 3:7, pages 1349-1356.
Crossref
Crossref
Anna Maria Mileo, Paola Nisticò & Stefania Miccadei. (2019) Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer. Frontiers in Immunology 10.
Crossref
Crossref
Haojie Yang, Jiong Wu, Jingjing Zhang, Zhigang Yang, Wei Jin, Ying Li, Lei Jin, Lu Yin, Hua Liu & Zhenyi Wang. (2019) Integrated bioinformatics analysis of key genes involved in progress of colon cancer. Molecular Genetics & Genomic Medicine 7:4.
Crossref
Crossref
Shixiong Jiang, Dazhuang Miao, Muhong Wang, Jiachen Lv, Yihui Wang & Jinxue Tong. (2019) MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. Journal of Cellular and Molecular Medicine 23:1, pages 630-640.
Crossref
Crossref
Wenzheng Yuan, Jintong Ji, Yan Shu, Jinhuang Chen, Sanguang Liu, Liang Wu, Zili Zhou, Zhengyi Liu, Qiang Tang, Xudan Zhang & Xiaogang Shu. (2018) Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer. Journal of Molecular Medicine 97:1, pages 89-102.
Crossref
Crossref
Zhe Pan, Yunpeng Xie, Jie Bai, Qiuyue Lin, Xiaonan Cui & Ningning Zhang. (2018)
Bufalin suppresses colorectal cancer cell growth through promoting autophagy
in vivo
and
in vitro
. RSC Advances 8:68, pages 38910-38918.
Crossref
Crossref
Tae Gyu Choi, Minh Nam Nguyen, Jieun Kim, Yong Hwa Jo, Miran Jang, Ngoc Ngo Yen Nguyen, Hyeong Rok Yun, Wonchae Choe, Insug Kang, Joohun Ha, Dean G Tang & Sung Soo Kim. (2018) Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer. The Journal of Pathology 246:1, pages 115-126.
Crossref
Crossref
Oluwaseun Adebayo Bamodu, Ching-Kuo Yang, Wei-Hong Cheng, David T.W. Tzeng, Kuang-Tai Kuo, Chun-Chih Huang, Li Deng, Michael Hsiao, Wei-Hwa Lee & Chi-Tai Yeh. (2018) 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by inducing hsa-miR-324 re-Expression. Cancers 10:8, pages 269.
Crossref
Crossref
Hai‑Ming Chen, Zheng‑Quan Lai, Hui‑Jun Liao, Jian‑Hui Xie, Yan‑Fang Xian, Yun‑Long Chen, Siu‑Po Ip, Zhi‑Xiu Lin & Zi‑Ren Su. (2018) Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells. International Journal of Molecular Medicine.
Crossref
Crossref
Yanlei Liu, Fan Yang, Wenwu Xiao, Ruiwu Liu, Hongyong Zhang, Xiaocen Li, Yousif H Ajena, Kit S Lam & Joseph W Leung. (2017) Discovery of specific targeting ligands as the biomarkers for colorectal cancer. Colorectal Cancer 6:4, pages 121-130.
Crossref
Crossref
Yuan Yin, Surui Yao, Yaling Hu, Yuyang Feng, Min Li, Zehua Bian, Jiwei Zhang, Yan Qin, Xiaowei Qi, Leyuan Zhou, Bojian Fei, Jian Zou, Dong Hua & Zhaohui Huang. (2017) The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Clinical Cancer Research 23:23, pages 7375-7387.
Crossref
Crossref
Reiko Satow, Shota Inagaki, Chiaki Kato, Makoto Shimozawa & Kiyoko Fukami. (2017) Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells. Cancer Science 108:12, pages 2405-2412.
Crossref
Crossref
Sneh Verma, Prasenjit Das & Vijay L. Kumar. (2017) Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis. Chemico-Biological Interactions 278, pages 84-91.
Crossref
Crossref
Ling Ye, Yuan Yang, Xin‑Yu Ma, Dan Li, Mei‑Li Xu, Pan Tan, Li‑Min Long, Hai‑Qin Wang, Ting Liu & Yong‑Hong Guo. (2017) Construction of a novel vector expressing Survivin‑shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells. Experimental and Therapeutic Medicine.
Crossref
Crossref
Hiroya Taniguchi, Satoru Iwasa, Kentaro Yamazaki, Takayuki Yoshino, Chika Kiryu, Yoshiharu Naka, Ei Leen Liew & Yuh Sakata. (2017)
Phase 1 study of
OCV
‐C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer
. Cancer Science 108:5, pages 1013-1021.
Crossref
Crossref
Chun-Hao Tsai, Amos C. Hung, Yuan-Yin Chen, Ya-Wen Chiu, Pei-Wen Hsieh, Yi-Chen Lee, Yu-Han Su, Po-Chih Chang, Stephen Chu-Sung Hu & Shyng-Shiou F. Yuan. (2017) 3’-hydroxy-4’-methoxy-β-methyl-β-nitrostyrene inhibits tumorigenesis in colorectal cancer cells through ROS-mediated DNA damage and mitochondrial dysfunction. Oncotarget 8:11, pages 18106-18117.
Crossref
Crossref
Mei Peng, Kwame Oteng Darko, Ting Tao, Yanjun Huang, Qiongli Su, Caimei He, Tao Yin, Zhaoqian Liu & Xiaoping Yang. (2017) Combination of metformin with chemotherapeutic drugs via different molecular mechanisms. Cancer Treatment Reviews 54, pages 24-33.
Crossref
Crossref
Zhen-zhen Pan, Hui-yuan Wang, Meng Zhang, Ting-ting Lin, Wen-yuan Zhang, Peng-fei Zhao, Yi-si Tang, Yong Xiong, Yuan-er Zeng & Yong-zhuo Huang. (2016) Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer. Acta Pharmacologica Sinica 37:8, pages 1110-1120.
Crossref
Crossref
Shushan Yan, Zengfang Wang, Zengyan Wang, Quanhong Duan, Xiaochen Wang, Jun Li & Beicheng Sun. (2016) Glutathione S-transferase M1 null genotype related to poor prognosis of colorectal cancer. Tumor Biology 37:8, pages 10229-10234.
Crossref
Crossref
Ye Zhang, Xingqian Hu, Xiaofei Miao, Kuiyu Zhu, Songkui Cui, Qingyang Meng, Jialin Sun & Tong Wang. (2016)
Micro
RNA
‐425‐5p regulates chemoresistance in colorectal cancer cells
via
regulation of Programmed Cell Death 10
. Journal of Cellular and Molecular Medicine 20:2, pages 360-369.
Crossref
Crossref
Daniele Fanale, Nadia Barraco, Angela Listì, Viviana Bazan & Antonio Russo. 2016. Non-coding RNAs in Colorectal Cancer. Non-coding RNAs in Colorectal Cancer
93
108
.
Daniele Fanale, Marta Castiglia, Viviana Bazan & Antonio Russo. 2016. Non-coding RNAs in Colorectal Cancer. Non-coding RNAs in Colorectal Cancer
207
228
.
Siao-Syun Guan, Chun-Chia Cheng, Ai-Sheng Ho, Chia-Chi Wang, Tsai-Yueh Luo, Tse-Zung Liao, Jungshan Chang, Cheng-Tien Wu & Shing-Hwa Liu. (2015)
Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection
in vivo
. Oncotarget 6:34, pages 36139-36155.
Crossref
Crossref
MOHD NIZAM ZAHARY, ABDUL AZIZ AHMAD AIZAT, GURJEET KAUR, LEE YEONG YEH, MAYA MAZUWIN & RAVINDRAN ANKATHIL. (2015) Polymorphisms of cell cycle regulator genes CCND1 G870A and TP53 C215G: Association with colorectal cancer susceptibility risk in a Malaysian population. Oncology Letters 10:5, pages 3216-3222.
Crossref
Crossref
Tung-Cheng Chang, Chi-Tai Yeh, Bamodu Oluwaseun Adebayo, Ying-Chin Lin, Li Deng, Yerra Koteswara Rao, Chun-Chih Huang, Wei-Hwa Lee, Alexander T.H. Wu, Michael Hsiao, Chih-Hsiung Wu, Liang-Shun Wang & Yew-Min Tzeng. (2015) 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype. Toxicology and Applied Pharmacology 288:2, pages 258-268.
Crossref
Crossref
Kathryn Ottolino-Perry, Sergio A. Acuna, Fernando A. Angarita, Clara Sellers, Siham Zerhouni, Nan Tang & J. Andrea McCart. (2015) Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer. Molecular Oncology 9:8, pages 1539-1552.
Crossref
Crossref
Do-Hee Kim & Young-Joon Surh. (2015) Chemopreventive and Therapeutic Potential of Phytochemicals Targeting Cancer Stem Cells. Current Pharmacology Reports 1:5, pages 302-311.
Crossref
Crossref
RUI HUANG, GUIYU WANG, YANNI SONG, QINGCHAO TANG, QI YOU, ZHENG LIU, YINGGANG CHEN, QIAN ZHANG, JIAYING LI, SHAN MUHAMMAND & XISHAN WANG. (2015) Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor. Molecular Medicine Reports 12:2, pages 2417-2424.
Crossref
Crossref
Aruna S. Jaiswal, Harekrushna Panda, Brian K. Law, Jay Sharma, Jitesh Jani, Robert Hromas & Satya Narayan. (2015) NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells. PLOS ONE 10:5, pages e0123808.
Crossref
Crossref
Lijun Ye, Gang Yuan, Fei Xu, Yueli Sun, Ziyan Chen, Miaohong Chen, Tianxiao Li, Pingping Sun, Shuxia Li & Jian Sun. (2014) The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells. Tumor Biology 36:5, pages 3447-3455.
Crossref
Crossref
Santosh N. Mokale, Pritam N. Dube, Swati A. Bhavale, Ibrahim Sayed, Afreen Begum, Manjusha C. Nevase, Vishakha R. Shelke & Abdul Mujaheed. (2014) Synthesis, in-vitro screening, and docking analysis of novel pyrrolidine and piperidine-substituted ethoxy chalcone as anticancer agents. Medicinal Chemistry Research 24:5, pages 1842-1856.
Crossref
Crossref
Victor E. ZotaAnthony M. Magliocco. (2015) Molecular Technologies in the Clinical Diagnostic Laboratory. Cancer Control 22:2, pages 142-151.
Crossref
Crossref
Senlin Zhao, Tao Jiang, Huamei Tang, Feifei Cui, Chenchen Liu, Feng Guo, Huijun Lu, Yingming Xue, Weiliang Jiang, Zhihai Peng & Dongwang Yan. (2015) Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy. Journal of Gastroenterology and Hepatology 30:4, pages 680-688.
Crossref
Crossref
Jie Chai, Wei Dong, Chao Xie, Lin Wang, Da-Li Han, Shan Wang, Hong-Liang Guo & Zong-Li Zhang. (2015) MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD. IUBMB Life 67:3, pages 191-201.
Crossref
Crossref
Thacker Pooja & Devarajan Karunagaran. (2014) Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620. European Journal of Pharmacology 742, pages 55-64.
Crossref
Crossref
Wen Pan, Yingying Cheng, Heyu Zhang, Baocai Liu, Xiaoning Mo, Ting Li, Lin Li, Xiaojing Cheng, Lianhai Zhang, Jiafu Ji, Pingzhang Wang & Wenling Han. (2014) CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest. Scientific Reports 4:1.
Crossref
Crossref
Dominique Brossard, Mathilde Lechevrel, Laïla El Kihel, Céline Quesnelle, Mohamed Khalid, Safa Moslemi & Jean-Marie Reimund. (2014) Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines. European Journal of Medicinal Chemistry 86, pages 279-290.
Crossref
Crossref
Kosuke Higashi, Shoichi Hazama, Atsuhiro Araki, Kiyoshi Yoshimura, Norio Iizuka, Shigefumi Yoshino, Takafumi Noma & Masaaki Oka. (2014) A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model. International Journal of Oncology.
Crossref
Crossref
Ming-Cheng Chen, Nien-Hung Lee, Tsung-Jung Ho, Hsi-Hsien Hsu, Chia-Hua Kuo, Wei-Wen Kuo, Yueh-Min Lin, Fuu-Jen Tsai, Chang-Hai Tsai & Chih-Yang Huang. (2014) Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells. Cancer Letters 349:1, pages 51-60.
Crossref
Crossref
Min Lu, Luhaoran Sun, Jin Zhou & Jing Yang. (2014) Dihydroartemisinin induces apoptosis in colorectal cancer cells through the mitochondria-dependent pathway. Tumor Biology 35:6, pages 5307-5314.
Crossref
Crossref
Audrey Gallud, Ophélie Vaillant, Ludovic T. Maillard, Dominique P. Arama, Joëlle Dubois, Marie Maynadier, Vincent Lisowski, Marcel Garcia, Jean Martinez & Nicolas Masurier. (2014) Imidazopyridine-fused [1,3]-diazepinones: Synthesis and antiproliferative activity. European Journal of Medicinal Chemistry 75, pages 382-390.
Crossref
Crossref
Aldo Germani, Antonio Matrone, Valentina Grossi, Alessia Peserico, Paola Sanese, Micaela Liuzzi, Rocco Palermo, Stefania Murzilli, Antonio Francesco Campese, Giuseppe Ingravallo, Gianluca Canettieri, Tugsan Tezil & Cristiano Simone. (2014) Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A. Cancer Letters 344:1, pages 110-118.
Crossref
Crossref
Valentina Grossi. (2014) p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance. World Journal of Gastroenterology 20:29, pages 9744.
Crossref
Crossref
Shoichi Hazama, Yusuke Nakamura, Hiroko Takenouchi, Nobuaki Suzuki, Ryouichi Tsunedomi, Yuka Inoue, Yoshihiro Tokuhisa, Norio Iizuka, Shigefumi Yoshino, Kazuyoshi Takeda, Hirokazu Shinozaki, Akira Kamiya, Hiroyuki Furukawa & Masaaki Oka. (2014) A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. Journal of Translational Medicine 12:1, pages 63.
Crossref
Crossref
Jose JG Marin, Alba G Blazquez, Maria A Serrano, Oscar Briz, Maria J Monte & Rocio IR Macias. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Jung-Jin Park & Minyoung Lee. (2013) Increasing the α 2, 6 Sialylation of Glycoproteins May Contribute to Metastatic Spread and Therapeutic Resistance in Colorectal Cancer. Gut and Liver 7:6, pages 629-641.
Crossref
Crossref
Nicolas Desbois, David Pertuit, Johnny Moretto, Claire Cachia, Bruno Chauffert & Florence Bouyer. (2013) cis-Dichloroplatinum(II) complexes tethered to dibenzo[c,h][1,6]naphthyridin-6-ones: Synthesis and cytotoxicity in human cancer cell lines in vitro. European Journal of Medicinal Chemistry 69, pages 719-727.
Crossref
Crossref
Kamilia M. Amin, Amal A.M. Eissa, Sahar M. Abou-Seri, Fadi M. Awadallah & Ghaneya S. Hassan. (2013) Synthesis and biological evaluation of novel coumarin–pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents. European Journal of Medicinal Chemistry 60, pages 187-198.
Crossref
Crossref